Amanda Winters

Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia

Daniel A. Pollyea, Brett M. Stevens, Courtney L. Jones et al. · Nature Medicine · 2018 · 768 citations · Full text

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +9

Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia

Shanshan Pei, Daniel A. Pollyea, Annika Gustafson et al. · Cancer Discovery · 2020 · 518 citations

Mixed-phenotype Acute Leukemia, Immunology, Pharmacotherapy +19

Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells

Brett M. Stevens, Courtney L. Jones, Daniel A. Pollyea et al. · Nature Cancer · 2020 · 282 citations · Full text

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Hematology +6

Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells

Courtney L. Jones, Brett M. Stevens, Daniel A. Pollyea et al. · Cell stem cell · 2020 · 216 citations · Full text

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +7

Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia

Evan Cherry, Diana Abbott, Maria L. Amaya et al. · Blood Advances · 2021 · 160 citations · Full text

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +12